EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antileishmanial and Immunomodulatory Activity of Paclitaxel and Docetaxel Combined with Miltefosine and Paromomycin

Estela Melcón-Fernández iD, Rafael Balaña-Fouce iD, Carlos García-Estrada iD, Rosa M Reguera iD, Celia Fernández-Rubio iD, Marta Cendón-Álvarez iD, Yolanda Pérez-Pertejo iD

International Journal of Molecular Sciences · 27.03.2026 · 27 (7) · 3055

DOI: 10.3390/ijms27073055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.03.2026. Verfasst von Estela Melcón-Fernández und 6 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Ciencias Biomédicas, Facultad de Veterinaria, Universidad de León, 24071 León, Spain. Hauptthemen laut MEDLINE: Paromomycin, Phosphorylcholine, Paclitaxel, Docetaxel. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dirección General de Universidades e Investigación Junta de Castilla y León, Dirección General de Universidades e Investigación https://ror.org/03mnxvp33, Junta de Castilla y León https://ror.org/02s8dab97.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A wide range of Leishmania species, transmitted by phlebotomine, cause leishmaniasis, which presents diverse clinical manifestations. Leishmaniasis has a high impact on vulnerable communities, primarily affecting people suffering from malnutrition or poor housing. Because leishmaniasis is associated with poverty, access to treatment is limited. In addition, high drug toxicity and therapeutic failure, related to drug resistance, remain major challenges. Therefore, there is a need to develop new therapeutic approaches that are safer and more effective. Drug combinations and repurposing are two strategies used in the development of treatments. The combination of drugs with different mechanisms of action can minimise resistance and allow dose reduction, increasing the likelihood of successful drug repurposing. This study evaluated the antileishmanial effects of combining antitumoral agents (paclitaxel and docetaxel) with standard drugs (miltefosine and paromomycin). Results demonstrated synergistic effects at higher doses. Furthermore, the antitumoral compounds enhanced the host immune response by promoting macrophage polarisation toward the M1 phenotype, essential for parasite control. These findings highlight a promising approach that could improve efficacy and reduce resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ParomomycinPhosphorylcholinePaclitaxelDocetaxelAntiprotozoal AgentsLeishmaniaLeishmaniasisImmunologic FactorsAnimalsDrug SynergismHumansMacrophagesMice

Stichwörter der Autor:innen

cytokinesdocetaxeldrug combinationsdrug repurposingleishmaniasismiltefosinepaclitaxelparomomycin

Substanzen

ParomomycinPhosphorylcholinePaclitaxelmiltefosineDocetaxelAntiprotozoal AgentsImmunologic Factors

Autor:innen und Institutionen

  • Departamento de Ciencias Biomédicas, Facultad de Veterinaria, Universidad de León, 24071 León, Spain.
  • Instituto de Biomedicina (IBIOMED), Universidad de León, Campus de Vegazana s/n, 24071 León, Spain.

ORCID-Profile: Estela Melcón-Fernández, Rafael Balaña-Fouce, Carlos García-Estrada, Rosa M Reguera, Celia Fernández-Rubio, Marta Cendón-Álvarez, Yolanda Pérez-Pertejo

Förderung

  • Dirección General de Universidades e Investigación Junta de Castilla y León
  • Dirección General de Universidades e Investigación https://ror.org/03mnxvp33
  • Junta de Castilla y León https://ror.org/02s8dab97

Zitieren

APA

Melcón-Fernández, E., Balaña-Fouce, R., García-Estrada, C., Reguera, R. M., Fernández-Rubio, C., Cendón-Álvarez, M., & Pérez-Pertejo, Y. (2026). Antileishmanial and Immunomodulatory Activity of Paclitaxel and Docetaxel Combined with Miltefosine and Paromomycin. International Journal of Molecular Sciences, 27(7), 3055. https://doi.org/10.3390/ijms27073055

Vancouver

Melcón-Fernández E, Balaña-Fouce R, García-Estrada C, Reguera RM, Fernández-Rubio C, Cendón-Álvarez M, et al. Antileishmanial and Immunomodulatory Activity of Paclitaxel and Docetaxel Combined with Miltefosine and Paromomycin. International Journal of Molecular Sciences. 2026;27(7):3055. doi:10.3390/ijms27073055

BibTeX
@article{MelcnFernndez2026,
  author = {Melcón-Fernández, Estela and Balaña-Fouce, Rafael and García-Estrada, Carlos and Reguera, Rosa M and Fernández-Rubio, Celia and Cendón-Álvarez, Marta and Pérez-Pertejo, Yolanda},
  title = {Antileishmanial and Immunomodulatory Activity of Paclitaxel and Docetaxel Combined with Miltefosine and Paromomycin},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {7},
  pages = {3055},
  doi = {10.3390/ijms27073055}
}
Kostenlos starten →